Diabetic Shoes Market: By Gender; By Type; By Distribution Channel; By Geography - With Forecast 2016-2021

  • ID: 3973924
  • Report
  • 142 pages
  • IndustryARC
1 of 3
High blood sugar can damage internal components of human body such as the nerves and blood vessels that do have connectivity to the foot. People with increased sugar levels have high risk of developing foot related issues such as pain and swelling. Today there are diabetic shoes available in the market that can promote healthy blood circulation in the human feet. Diabetic shoes are of different categories and due to increase in the customer awareness for the healthcare products and the trending designs of these therapeutic shoes, the market has gained significant traction in the past years.

The report “Global Diabetic Shoes market” for the projected period 2016 to 2021 has been segmented on three different parameters. The global Diabetic Shoes market has been primarily studied on the basis of demographics. The Diabetic Shoes market has also been studied on the basis of different categories such as Athletics, Sandals and many more. The market has also been studied on the premise of different geographies based on the data obtained from the primaries and secondary research conducted amid the report formation.

Middle East and North America are the mature market for diabetic shoes as per the initial estimations as per the initial research results. This can be attributed to the presence of the highest number of diabetic patients in countries such as Saudi Arabia, Yemen, Iraq and USA. The level of awareness for these medical products in the customers present in these regions is considerably higher than the Asian and European customers. This difference of awareness can also be accounted for high purchasing power and use of advanced marketing channels used by the companies in the developed geographies. The increasing number of aging population and diabetic patients in the Asia-Pacific and European countries is laying down grounds for the growth of the diabetic shoe market in the coming years. However, the global Diabetic Shoes market is being restrained by factors such as low branding and marketing of diabetic shoes and also because of the stringent barriers and regulations for entering this particular market.

Following are the few leading companies present in the global Diabetic Shoes market:

ThromboGenics NV
Allergan PLC
Bayer AG
Regeneron Pharmaceuticals Inc.

Novartis AG
The Diabetic Shoes market report also comprises of the leading companies profiled in an extremely descriptive manner. The company profiles include financial summaries, strategies, recent developments and product portfolios of the leading companies in the Diabetic Shoes market. The report also incorporates a profound study of the market entropy, market forces and strategic analysis of the Diabetic Shoes market.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Diabetic Shoes – Market Overview

2. Executive Summary

3. Diabetic Shoes – Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis

4. Diabetic Shoes– Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Diabetic Shoes Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Diabetic Shoes market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Diabetic Shoes market – By Gender
6.1. Men
6.2. Women

7. Diabetic Shoes market – By Type
7.1. Athletics
7.2. Casuals
7.3. Sandals
7.4. Floaters
7.5. Boots

8. Diabetic Shoes market – By Distribution Channel
8.1. Exclusive Brand Stores
8.2. Retailers (e.g. Lifestyle, Shoppers Stop)
8.3. Online Platform
8.4. Distributers
8.5. Unorganized Channel

9. Diabetic Shoes market- By Geography
9.1. Introduction
9.2. Global Study
9.3. Americas
9.3.1. USA
9.3.2. Canada
9.3.3. Mexico
9.3.4. Brazil
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. France
9.4.3. Germany
9.4.4. Others
9.5. APAC
9.5.1. China
9.5.2. India
9.5.3. Australia
9.5.4. Others
9.6. RoW
9.6.1. Middle East
9.6.2. Africa

10. Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs and Partnerships

11. Company Profiles
11.1. Orthofeets
11.2. New Balance Athletic Shoe, Inc.,
11.3. Dr. Comfort
11.4. Propét USA, Inc.
11.5. P.W.Minor
11.6. Aetrex Worldwide, Inc.
11.7. Pedilite LLC
11.8. Oasis Footwear,LLC
11.9. SureFit
11.10. InStride Shoes LLC
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown